Company / Interest Expense per Share
Twist Bioscience Corp Interest Expense per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2023
5-year range
$0.00 / $0.01
FY2019-FY2023
Trend
-94.1%
vs FY2022
Sector context
#38 of 41
Health Care
What the data says
Among 41 Health Care companies, Twist Bioscience Corp is in the top 7% for interest expense per share. Interest Expense per Share has declined for 5 consecutive years, from $470.10 in FY2018 to $0.00 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -95.5%.
Improved from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -83.6%
- 5-Year CAGR
- -95.5%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 41This company $0.00 Sector average $10.31
▼
-100.0% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's interest expense per share has declined for 5 consecutive years.
- In FY2023, interest expense per share decreased 94.1% year-over-year.
- Ranks #38 out of 41 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -94.1% |
| FY2022 | $0.00 | -80.5% |
| FY2021 | $0.01 | -62.1% |
| FY2020 | $0.02 | -57.4% |
| FY2019 | $0.05 | -100.0% |
| FY2018 | $470.10 | +125823735.8% |
| FY2017 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026